Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Moderna Aktie: Grippe-Impfstoff triumphiert in Studie


Durchbruch für die Moderna-Pipeline: Der mRNA-Grippe-Impfstoff mRNA-1010 schneidet in der entscheidenden Phase-3-Studie deutlich besser…

Der Beitrag Moderna Aktie: Grippe-Impfstoff triumphiert in Studie erschien zuerst auf kapitalmarktexperten.de.


Quelle kapitalmarktexperten.de

Moderna Inc. Stock

€25.00
-0.460%
Moderna Inc. shows a slight decrease today, losing -€0.115 (-0.460%) compared to yesterday.
Based on 9 Buy predictions and 10 Sell predictions the sentiment towards Moderna Inc. is rather balanced.
With a target price of 22 € there is a slightly negative potential of -11.98% for Moderna Inc. compared to the current price of 25.0 €.
Like: 0
Share

Comments